Successful retreatment with osimertinib after osimertinib-induced acute pulmonary embolism in a patient with lung adenocarcinoma: A case report

Pulmonary embolism (PE) can be life-threatening, and it is challenging to diagnose because of its nonspecific signs and symptoms. PE is also an important potential risk of osimertinib treatment, however, clinical courses regarding retreatment after osimertinib-induced acute pulmonary embolism remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiroyama, Takayuki, Hayama, Manabu, Satoh, Shingo, Nasu, Shingo, Tanaka, Ayako, Morita, Satomu, Morishita, Naoko, Suzuki, Hidekazu, Okamoto, Norio, Hirashima, Tomonori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121160/
https://www.ncbi.nlm.nih.gov/pubmed/27896061
http://dx.doi.org/10.1016/j.rmcr.2016.11.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121160/
https://www.ncbi.nlm.nih.gov/pubmed/27896061
http://dx.doi.org/10.1016/j.rmcr.2016.11.009

Ejemplares similares